Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,179 | -10,906 | -12,300 | -9,949 | -689 |
| Depreciation Amortization | 5,730 | 5,152 | 5,782 | 676 | 50 |
| Income taxes - deferred | N/A | N/A | N/A | -1,318 | -578 |
| Accounts receivable | 862 | -1,085 | 3 | -340 | -28 |
| Accounts payable and accrued liabilities | 2,710 | 677 | 901 | 351 | 58 |
| Other Working Capital | 7,862 | -2,878 | 3,096 | 1,057 | 175 |
| Other Operating Activity | 11,760 | 3,051 | 1,376 | 7,129 | 40 |
| Operating Cash Flow | $-2,254 | $-5,990 | $-1,141 | $-2,393 | $-972 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,328 | -2,242 | -167 | -6,007 | -340 |
| Net Acquisitions | -138 | -1,681 | -556 | -1,900 | -174 |
| Purchase Sale Intangibles | -1,131 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -695 | 5 | -164 | 64 | 151 |
| Investing Cash Flow | $-5,161 | $-3,918 | $-887 | $-7,843 | $-363 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,416 | 2,580 | 2,119 | 3,252 | 1,500 |
| Debt Repayment | -3,903 | -4,584 | -581 | N/A | N/A |
| Common Stock Issued | 658 | 13,300 | N/A | 5,885 | 1,496 |
| Other Financing Activity | -124 | -19 | 0 | 0 | 0 |
| Financing Cash Flow | $6,046 | $11,277 | $1,538 | $9,137 | $2,996 |
| Beginning Cash Position | 1,455 | 85 | 575 | 1,674 | 14 |
| End Cash Position | 86 | 1,455 | 85 | 575 | 1,674 |
| Net Cash Flow | $-1,369 | $1,370 | $-490 | $-1,099 | $1,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,254 | -5,990 | -1,141 | -2,393 | -972 |
| Capital Expenditure | -4,328 | -2,242 | -167 | -6,007 | -340 |
| Free Cash Flow | -6,582 | -8,232 | -1,309 | -8,400 | -1,313 |